top of page
Insights to inspire Better Portfolio Decisions
Expert perspectives, research, and real-world insights to advance portfolio thinking and smarter pharma decisions.


Reflections on Risk
In many cases, the only risk quantified in development project investment cases is PTRS (Probability of Technical and Regulatory Success). While technical failures are leading reasons for project cancellations, other critical risks often go unaddressed. Here are three additional types of risks we discussed in the presentation: 👉 Operational Risks These include delays in timelines and increases in development costs. Timeline delays harm project value by delaying revenue and p

Magnus Ytterstad
Dec 10, 20242 min read


Making Dependencies Count: Smarter Portfolio Decisions
Captario SUM now offers centralized portfolio-level dependency modeling, helping teams manage interdependencies, toggle assumptions, and reduce risk across drug development portfolios.

Magnus Ytterstad
Dec 6, 20242 min read


Pharma Wars: A New Drug Development Era
May 25th was the day when the first ever Star Wars movie, entitled "Star Wars: A New Hope," was released in 1977. As an homage to this,...

Captario
May 23, 20232 min read


Captario Presents at Bio-IT in Boston on "Embracing Trends in Risk Modeling and Analysis"
Don't miss our brilliant analysts Kate Bernstein and Anna Sarkisyan make their presentation "Strategic Uncertainty Management in 2023:...
lizkoch1
May 15, 20231 min read


Captario Spearheads the Pharma Industry Through the Launch of State-of-the-Art Managed Portfolios
Gothenburg, Sweden – Captario, the leading Swedish pharmaceutical strategic decision-making SaaS company, is pleased to announce the...

Captario
May 15, 20232 min read


Benchmarking the Pharma Industry: Trends in Pharma Decision-Making
At Captario, we strive to provide best-in-class tools and services to our clients and partners. As such, we continuously seek out...

Captario
May 8, 20231 min read
bottom of page